Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 81-87 , April 2006

Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients

  • Jonathan Sorof

      Affiliations

    • Cardiovascular Clinical Research, AstraZeneca LP, C4B-717, 1800 Concord Pike, Wilmington, DE 19803, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 302 885 0250; fax: +1 302 885 5450.
    • ,
  • Christian Berne

      Affiliations

    • Medicinkliniken, Akademiska Sjukhuset, Uppsala, Sweden
    • ,
  • Annica Siewert-Delle

      Affiliations

    • AstraZeneca, Södertälje, Sweden
    • ,
  • Leif Jørgensen

      Affiliations

    • AstraZeneca, Södertälje, Sweden
    • ,
  • Philip Sager

      Affiliations

    • Cardiovascular Clinical Research, AstraZeneca LP, C4B-717, 1800 Concord Pike, Wilmington, DE 19803, USA
    • ,
  • on behalf of the URANUS study investigators

Received 27 June 2005 ,Revised 26 August 2005 ,Accepted 2 September 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0168-8227(05)00368-2

doi: 10.1016/j.diabres.2005.09.004

Diabetes Research and Clinical Practice
Volume 72, Issue 1 , Pages 81-87 , April 2006

Article Tools

* Image Usage & Resolution